🇺🇸 FDA
Pipeline program

ORKA-001 Induction Dose

ORKA-001-112

Phase 2 small_molecule active

Quick answer

ORKA-001 Induction Dose for Plaque Psoriasis is a Phase 2 program (small_molecule) at Oruka Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Oruka Therapeutics
Indication
Plaque Psoriasis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials